VYGR

Voyager Therapeutics, Inc.

Insider trading activity for Voyager Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

-$298K

net selling

Bought(0 · 0 insiders): $0
Sold(11 · 4 insiders): $298K

Transaction history

The 47 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Nov 1	Swartz Robin	President	AGRANT◆	318,500	—	—	—	Open the original filing on SEC.gov
Nov 1	Swartz Robin	President	AGRANT	68,250	—	—	+34.2%	Open the original filing on SEC.gov
Nov 1	Carter Todd Alfred	Chief Scientific Officer	AGRANT◆	154,000	—	—	—	Open the original filing on SEC.gov
Nov 1	Carter Todd Alfred	Chief Scientific Officer	AGRANT	33,000	—	—	+22.7%	Open the original filing on SEC.gov
Jun 9	Vitale Nancy	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Scangos George A	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Pierce Glenn	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Onyia Jude	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	MacKey Catherine J	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Hyman Steven	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Higgins Michael J	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Geraghty James A	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Colon Grace	Director	AGRANT◆	30,000	—	—	—	Open the original filing on SEC.gov
Apr 2	Sandrock Alfred	President and CEO	SSELL◷	11,511	$3.87	$44.5K	-2.4%	Open the original filing on SEC.gov
Apr 1	Shiferman Gregory L.	SVP and General Counsel	AGRANT	50,000	—	—	—	Open the original filing on SEC.gov
Feb 24	Swartz Robin	COO & Cbo	SSELL◷	6,458	$3.77	$24.3K	-3.1%	Open the original filing on SEC.gov
Feb 24	Sandrock Alfred	President and CEO	SSELL◷	14,197	$3.79	$53.8K	-2.9%	Open the original filing on SEC.gov
Feb 24	Jorgensen Nathan D.	Chief Financial Officer	SSELL◷	4,668	$3.77	$17.6K	-3.0%	Open the original filing on SEC.gov
Feb 24	Carter Todd Alfred	Chief Scientific Officer	SSELL◷	4,174	$3.76	$15.7K	-2.8%	Open the original filing on SEC.gov
Feb 18	Swartz Robin	COO & Cbo	SSELL◷	3,882	$3.44	$13.4K	-1.8%	Open the original filing on SEC.gov
Feb 18	Sandrock Alfred	President and CEO	SSELL◷	11,732	$3.41	$40K	-2.3%	Open the original filing on SEC.gov
Feb 18	Carter Todd Alfred	Chief Scientific Officer	SSELL◷	3,301	$3.44	$11.4K	-2.1%	Open the original filing on SEC.gov
Feb 10	Swartz Robin	COO & Cbo	SSELL	4,569	$3.85	$17.6K	-2.1%	Open the original filing on SEC.gov
Feb 10	Sandrock Alfred	President and CEO	SSELL	12,192	$3.78	$46.1K	-2.3%	Open the original filing on SEC.gov
Feb 10	Carter Todd Alfred	Chief Scientific Officer	SSELL	3,525	$3.85	$13.6K	-2.3%	Open the original filing on SEC.gov
Feb 6	Swartz Robin	COO & Cbo	AGRANT◆	210,000	—	—	—	Open the original filing on SEC.gov
Feb 6	Swartz Robin	COO & Cbo	AGRANT	45,000	—	—	+26.5%	Open the original filing on SEC.gov
Feb 6	Sandrock Alfred	President and CEO	AGRANT◆	402,500	—	—	—	Open the original filing on SEC.gov
Feb 6	Sandrock Alfred	President and CEO	AGRANT	86,250	—	—	+19.8%	Open the original filing on SEC.gov
Feb 6	Jorgensen Nathan D.	Chief Financial Officer	AGRANT◆	150,500	—	—	—	Open the original filing on SEC.gov
Feb 6	Jorgensen Nathan D.	Chief Financial Officer	AGRANT	32,250	—	—	+26.0%	Open the original filing on SEC.gov
Feb 6	Ferguson Toby	Chief Medical Officer	AGRANT◆	210,000	—	—	—	Open the original filing on SEC.gov
Feb 6	Ferguson Toby	Chief Medical Officer	AGRANT	45,000	—	—	+32.4%	Open the original filing on SEC.gov
Feb 6	Carter Todd Alfred	Chief Scientific Officer	AGRANT◆	154,000	—	—	—	Open the original filing on SEC.gov
Feb 6	Carter Todd Alfred	Chief Scientific Officer	AGRANT	33,000	—	—	+26.7%	Open the original filing on SEC.gov
Jan 6	Shiferman Gregory L.	SVP and General Counsel	AGRANT◆	100,000	—	—	—	Open the original filing on SEC.gov
Oct 3, 2025	Jorgensen Nathan D.	Chief Financial Officer	SSELL◷	7,666	$4.78	$36.6K	-5.8%	Open the original filing on SEC.gov
Aug 18, 2025	Ferguson Toby	Chief Medical Officer	SSELL	19,000	$3.73	$70.9K	-12.0%	Open the original filing on SEC.gov
Jun 3, 2025	Vitale Nancy	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Scangos George A	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Pierce Glenn	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Onyia Jude	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	MacKey Catherine J	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Hyman Steven	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Higgins Michael J	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Geraghty James A	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov
Jun 3, 2025	Colon Grace	Director	AGRANT◆	24,000	—	—	—	Open the original filing on SEC.gov

AGRANT◆—

Swartz Robin · PresidentNov 1

318,500 sh

AGRANT—

Swartz Robin · PresidentNov 1

68,250 sh · +34.2% own

AGRANT◆—

Carter Todd Alfred · Chief Scientific…Nov 1

154,000 sh

AGRANT—

Carter Todd Alfred · Chief Scientific…Nov 1

33,000 sh · +22.7% own

AGRANT◆—

Vitale Nancy · DirectorJun 9

30,000 sh

AGRANT◆—

Scangos George A · DirectorJun 9

30,000 sh

AGRANT◆—

Pierce Glenn · DirectorJun 9

30,000 sh

AGRANT◆—

Onyia Jude · DirectorJun 9

30,000 sh

AGRANT◆—

MacKey Catherine J · DirectorJun 9

30,000 sh

AGRANT◆—

Hyman Steven · DirectorJun 9

30,000 sh

AGRANT◆—

Higgins Michael J · DirectorJun 9

30,000 sh

AGRANT◆—

Geraghty James A · DirectorJun 9

30,000 sh

AGRANT◆—

Colon Grace · DirectorJun 9

30,000 sh

SSELL◷$44.5K

Sandrock Alfred · President and CEOApr 2

11,511 sh @ $3.87 · -2.4% own

AGRANT—

Shiferman Gregory L. · SVP and General…Apr 1

50,000 sh

SSELL◷$24.3K

Swartz Robin · COO & CboFeb 24

6,458 sh @ $3.77 · -3.1% own

SSELL◷$53.8K

Sandrock Alfred · President and CEOFeb 24

14,197 sh @ $3.79 · -2.9% own

SSELL◷$17.6K

Jorgensen Nathan D. · Chief Financial…Feb 24

4,668 sh @ $3.77 · -3.0% own

SSELL◷$15.7K

Carter Todd Alfred · Chief Scientific…Feb 24

4,174 sh @ $3.76 · -2.8% own

SSELL◷$13.4K

Swartz Robin · COO & CboFeb 18

3,882 sh @ $3.44 · -1.8% own

SSELL◷$40K

Sandrock Alfred · President and CEOFeb 18

11,732 sh @ $3.41 · -2.3% own

SSELL◷$11.4K

Carter Todd Alfred · Chief Scientific…Feb 18

3,301 sh @ $3.44 · -2.1% own

SSELL$17.6K

Swartz Robin · COO & CboFeb 10

4,569 sh @ $3.85 · -2.1% own

SSELL$46.1K

Sandrock Alfred · President and CEOFeb 10

12,192 sh @ $3.78 · -2.3% own

SSELL$13.6K

Carter Todd Alfred · Chief Scientific…Feb 10

3,525 sh @ $3.85 · -2.3% own

AGRANT◆—

Swartz Robin · COO & CboFeb 6

210,000 sh

AGRANT—

Swartz Robin · COO & CboFeb 6

45,000 sh · +26.5% own

AGRANT◆—

Sandrock Alfred · President and CEOFeb 6

402,500 sh

AGRANT—

Sandrock Alfred · President and CEOFeb 6

86,250 sh · +19.8% own

AGRANT◆—

Jorgensen Nathan D. · Chief Financial…Feb 6

150,500 sh

AGRANT—

Jorgensen Nathan D. · Chief Financial…Feb 6

32,250 sh · +26.0% own

AGRANT◆—

Ferguson Toby · Chief Medical…Feb 6

210,000 sh

AGRANT—

Ferguson Toby · Chief Medical…Feb 6

45,000 sh · +32.4% own

AGRANT◆—

Carter Todd Alfred · Chief Scientific…Feb 6

154,000 sh

AGRANT—

Carter Todd Alfred · Chief Scientific…Feb 6

33,000 sh · +26.7% own

AGRANT◆—

Shiferman Gregory L. · SVP and General…Jan 6

100,000 sh

SSELL◷$36.6K

Jorgensen Nathan D. · Chief Financial…Oct 3, 2025

7,666 sh @ $4.78 · -5.8% own

SSELL$70.9K

Ferguson Toby · Chief Medical…Aug 18, 2025

19,000 sh @ $3.73 · -12.0% own

AGRANT◆—

Vitale Nancy · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Scangos George A · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Pierce Glenn · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Onyia Jude · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

MacKey Catherine J · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Hyman Steven · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Higgins Michael J · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Geraghty James A · DirectorJun 3, 2025

24,000 sh

AGRANT◆—

Colon Grace · DirectorJun 3, 2025

24,000 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 40 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →